FDA
-
-
-
-
-
-
-
The Next Generation of the GLP-1 Revolution Is Already Underway
-
-
-
-
-
-
-
Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy
-
-
-
-
-
-
-
Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note
-
-
-
-
-
-
-
Amgen's Repatha reduces heart attack risk by 25% in major study
-
-
-
-
-
-
-
FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
-
-
-
-
-
-
-
Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension Study in Adults With Moderate to Severe Atopic Dermatitis
-
-
-
-
-
-
-
NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer
-
322,996 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

